Microangiopathic haemolysis associated with occult carcinoma

Clin Lab Haematol. 1991;13(3):245-9. doi: 10.1111/j.1365-2257.1991.tb00279.x.

Abstract

Microangiopathic haemolytic anaemia (MAHA) is a well recognized complication of disseminated carcinoma and its treatment. It is however, rarely seen with localized carcinoma. The case presented here is a previously unreported association of a patient, who having been successfully treated for MAHA, was found to have occult breast carcinoma on a routine screening mammogram six months after the haemolytic episode.

Publication types

  • Case Reports

MeSH terms

  • Adenocarcinoma / blood
  • Adenocarcinoma / complications*
  • Adenocarcinoma / diagnostic imaging
  • Anemia, Hemolytic / complications*
  • Anemia, Hemolytic / drug therapy
  • Anemia, Hemolytic / therapy
  • Breast Neoplasms / blood
  • Breast Neoplasms / complications*
  • Breast Neoplasms / diagnostic imaging
  • Dexamethasone / therapeutic use
  • Epoprostenol / therapeutic use
  • Female
  • Humans
  • Middle Aged
  • Neoplasms, Unknown Primary / blood
  • Neoplasms, Unknown Primary / complications*
  • Plasma Exchange
  • Pneumonia / complications
  • Radiography
  • Vincristine / therapeutic use

Substances

  • Vincristine
  • Dexamethasone
  • Epoprostenol